Ye Wang

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Molecular Dynamics Simulations

Infectious Diseases

Diffuse Large B Cell Lymphoma

Protein Protein

Top Venues

Molecules (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Shuo Wang, Xuexun Fang, Ye Wang
In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19. Molecules (Basel, Switzerland) 27 (13) (2022)
Dahai Yu, Linlin Wang, Ye Wang
Recent Advances in Application of Computer-Aided Drug Design in Anti-Influenza A Virus Drug Discovery. International journal of molecular sciences 23 (9) (2022)
Xin Meng, Ye Wang
Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor. Molecules (Basel, Switzerland) 26 (23) (2021)
Jinrui Zhang, Li Ren, Ye Wang, Xuexun Fang
In silico study on identification of novel MALT1 allosteric inhibitors. RSC advances 9 (67) (2019)
Yanyan Wang, Ye Wang, Song An, Jinrui Zhang, Yuqian Han, Jinge Xu, Fang Yu, Dahai Yu, Xuexun Fang
Potent and selective inhibition of matrix metalloproteinases by lanthanide trichloride. RSC advances 8 (26) (2018)
Ye Wang, Chengkai Zhang, Song An, Xuexun Fang, Dahai Yu
Engineering substrate promiscuity in 2,4-dichlorophenol hydroxylase by in silico design. RSC advances 8 (38) (2018)